Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patient death
Biotech
Capsida pauses phase 1 gene therapy trial after child dies
AbbVie, CRISPR Therapeutics and Eli Lilly have all struck deals with Capsida.
Nick Paul Taylor
Sep 11, 2025 7:30am
Rocket's gene therapy free from FDA hold
Aug 20, 2025 10:40am
Schrödinger abandons CDC7 inhibitor linked to 2 patient deaths
Aug 14, 2025 8:23am
CytomX reports patient death from kidney injury in ADC trial
Aug 14, 2025 6:45am
Allogene reports patient death tied to mAb in CAR-T pivotal trial
Aug 1, 2025 8:30am
Fierce Pharma
FDA backtracks on Sarepta's gene therapy Elevidys in DMD
Jul 28, 2025 6:02pm